SPONSOR
Tang-Du Hospital
Total Trials
4
Recruiting
4
Phases
Phase 1, Phase 2
Conditions studied: Breast CancerChemo-brainEndocrine TherapyNMO Spectrum DisorderNSCLC (Non-small Cell Lung Cancer)Esophageal Squamous Cell CarcinomaIvonescimabNeoadjuvant
Tang-Du Hospital is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Breast Cancer, Chemo-brain, Endocrine Therapy, NMO Spectrum Disorder.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Tang-Du Hospital
How many clinical trials has Tang-Du Hospital sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Tang-Du Hospital, of which 4 are actively recruiting participants. These trials cover conditions including Breast Cancer, Chemo-brain, Endocrine Therapy. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Tang-Du Hospital research focus on?
Tang-Du Hospital clinical trials span Breast Cancer, Chemo-brain, Endocrine Therapy, NMO Spectrum Disorder, NSCLC (Non-small Cell Lung Cancer), and additional conditions. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Tang-Du Hospital clinical trial?
To participate in a Tang-Du Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Tang-Du Hospital trials with current recruitment status updated daily.
Clinical Trials by Tang-Du Hospital
NCT05305092
Recruiting
Assessment of Brain Cognitive Impairment in Breast Cancer
Breast Cancer
NCT07377305
Recruiting
Efficacy and Safety of Transcranial Temporal Interference Stimulation (tTIS) for Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder (NMOSD)
NMO Spectrum Disorder
NCT07354061 Phase 1, Phase 2
Recruiting
Neoadjuvant Therapy With Ensartinib Combined With Chemotherapy for ALK-positive Non - Small Cell Lung Cancer (NSCLC)
NSCLC (Non-small Cell Lung Cancer)
NCT07385001 Phase 1, Phase 2
Recruiting
A Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab (AK112) Combined With Albumin-Paclitaxel and Cisplatin as Neoadjuvant Therapy for ESCC
Esophageal Squamous Cell Carcinoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology